News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce’s PF614-MPAR
Wednesday, September 14, 2022Ensysce Biosciences Inc a clinicalstage biotech company applying transformative chemistry to improve prescription drug safety and Quotient Sciences a drug development and manufacturing accelerator has announced a partnership to support the developmen...
MD Anderson and Radiopharm Theranostics Launch Joint Venture to Develop Novel Radiopharmaceuticals
Wednesday, September 14, 2022The University of Texas MD Anderson Cancer Center and Radiopharm Theranostics Limited announced the launch of Radiopharm Ventures LLC a joint venture company created to develop novel radiopharmaceutical therapeutic products for cancer Radiopharm Vent...
MagBio Receives 510(k) Clearance and CE Mark for MagXtract Collection Tube For COVID-19 Testing
Tuesday, September 13, 2022MagBio Genomics Inc a global company focused on magnetic beadbased products for molecular diagnostics and liquid biopsy genomic research announced US Food and Drug Administration FDA k clearance CE Mark approval and global launch of its MagXtract Col...
KCAS Expands Its Transatlantic Presence with the Acquisition of France-based Active Biomarkers
Tuesday, September 13, 2022KCAS Bioanalytical and Biomarker Services KCAS a leading bioanalytical contract research organization CRO backed by Vitruvian Partners closed the purchase of Active Biomarkers located in Lyon France Active Biomarkers is a renowned assay development a...
Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 Program by Roche
Thursday, September 08, 2022Good Therapeutics a privately held company today announced it has entered into a definitive merger agreement to be acquired by Roche With this acquisition Roche will gain rights to Good Therapeutics innovative conditionally active PDregulated IL prog...
Mirati Therapeutics Presents Late-Breaking Adagrasib Monotherapy and Combination Results in Advanced Colorectal Cancer
Thursday, September 08, 2022Mirati Therapeutics Inc a clinicalstage targeted oncology company today announced results from KRYSTAL a multicohort Phase study evaluating adagrasib with or without cetuximab in patients with advanced CRC harboring a KRASGC mutation These exciting...
Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
Wednesday, September 07, 2022Charles River Laboratories International Inc and Cure AP a nonprofit foundation dedicated to raising funds and awareness about AdapterProtein Hereditary Spastic Paraplegia AP HSP today announced a manufacturing collaboration Charles River a contract...
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar Stimufend® (pegfilgrastim - fpgk)
Wednesday, September 07, 2022Fresenius Kabi a global health care company that specializes in pharmaceuticals medical technologies and nutrition products for critical and chronic conditions announced today that the United States US Food and Drug Administration FDA has approved it...
U.S. FDA approves first treatment option for generalized pustular psoriasis flares in adults
Tuesday, September 06, 2022The US Food and Drug Administration is the first regulatory authority to approve spesolimab as a treatment option for generalized pustular psoriasis GPP flares in adults Boehringer Ingelheim announced today Spesolimab marketed in the US as SPEVIGO is...
Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration
Tuesday, September 06, 2022Avacta Group plc a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and preCISION platforms announces that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to th...
